524715:BOM
Sun Pharmaceutical Industries Ltd
1.769,10 ₹
arrow_upward
+0,57%(+10,00) 1D
13. okt., 15.55.55 GMT+5.30 · INR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for 524715...
Ã…bn
1.762,30 ₹
Høj
1.769,70 ₹
Lav
1.751,50 ₹
Markedsværdi
4,24Â bio.
Gns. vol.
117,46Â t
Volumen
28,07Â t
Udbytte
0,90Â %
Kvartalsvis udbytte
4,00 ₹
Ex-dato
7. jul. 2026
P/E-forhold
35,07
Højeste i 52 uger
2.047,55 ₹
Laveste i 52 uger
1.583,60 ₹
Indtægt pr. aktie
50,44 ₹
Aktier i omløb
0,00
Antal ansatte
47Â t
Ã…bn
1.762,30 ₹
Høj
1.769,70 ₹
Lav
1.751,50 ₹
Markedsværdi
4,24Â bio.
Gns. vol.
117,46Â t
Volumen
28,07Â t
Udbytte
0,90Â %
Kvartalsvis udbytte
4,00 ₹
Ex-dato
7. jul. 2026
P/E-forhold
35,07
Højeste i 52 uger
2.047,55 ₹
Laveste i 52 uger
1.583,60 ₹
Indtægt pr. aktie
50,44 ₹
Aktier i omløb
0,00
Antal ansatte
47Â t
Nyhedshistorier
Fra webkilder og nyhedspartnere
ad-hoc-news.de
·
for 10 timer siden
Geojit raises target for Sun Pharma stock to INR 2,070.00
Business Standard
·
for 12 timer siden
Sun Pharma board approves plan to raise up to ₹10,000 crore via NCDs
TipRanks
·
for 1 dag siden
Sun Pharma Clears INR 10,000 Crore NCD Plan as Independent Director Resigns
TipRanks
·
for 1 dag siden
Sun Pharma Plans Up to INR 10,000 Crore NCD Issue as Independent Director Resigns
Profil
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Om Sun Pharmaceutical Industries Ltd
Administrerende direktør-
Ansatte47Â t
Grundlagt1983
HovedsædeGoregaon East, Mumbai, Indien
Sektor-
Websitesunpharma.com